Basel Area shapes future health innovations
The most important success factor of the Basel region (in the language of Economic Development, the "Basel Area") is its capacity for constant transformation. From being the centre of the pharmaceutical industry, Basel has developed into Europe's leading life sciences cluster with strong companies in biotechnology, digital health, health technologies and personalised medicine.
This was the gist of a recent article in «Future Health», a supplement of Neue Zürcher Zeitung (NZZ), one of the preeminent and most traditional news sources in the German speaking world.
A big thank you to all the partners who made this article possible as part of the NZZ supplement on "Future Health". In addition to Karin Sartorius from Economic Development at AWA Basel-Stadt, these were Dorothee Frei Hasler (Department of Health, Canton Basel-Stadt), Robert Sum (Economic Development Baselland) as well as Martin Jordan and Julia Meyer (both from Basel Area Business & Innovation).
Translation of an article (“Basel Area prägt Gesundheitsinnovationen der Zukunft») that appeared in the supplement "Future Health" by Neue Zürcher Zeitung (10 April 2021, p. 4)